|
Alzheimer''s Disease Neuroimaging Initiative
|
Research Initiative
|
FDA
|
NIA, NIBIB
|
This collaboration is meant to develop biomarkers of Alzheimer’s Disease in elderly subjects. A major goal of the study has been to establish and validate MRI and PET images, cerebral spinal fluid, and blood biomarkers as predictors of the disease.
|
|
America''s Children Forum on Health and Family Statistics
|
Resource Development
|
SAMHSA
|
NIDA
|
NIDA contributes data from the Monitoring the Future survey on illicit drugs, alcohol and tobacco trends.
|
|
American Association of Blood Bank (AABB) International Biovigilance Network Task Force
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NHLBI
|
The task force is a collaboration between the American Association of Blood Banks, the government, and other agencies focused on tracking and analyzing adverse reactions and incidents associated with blood collection and transfusion, as well as organ and cell donation and transplantation.
|
|
American Association of Pediatrics (AAP) Executive Committee, Section on Perinatal Pediatrics
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
The mission of the Section on Perinatal Pediatrics of the American Academy of Pediatrics (AAP) Executive Committee: To improve the health of the pregnant mother, the unborn fetus and the newly-born child through the sponsorship of programs which encourage the professional growth of the neonatal-perinatal providers, continuously improve clinical care delivery, support continuing and postgraduate education, foster basic, clinical and outcomes research and seek to attain federal and local funding for programs directed towards maternal/child health. The Section on Perinatal Pediatrics is the home organization for specialists in Neonatal-Perinatal Medicine and also welcomes affiliate members working in related disciplines. At a membership of nearly 3,500, the Section is the largest specialty subgroup of the AAP. The Section''s highest priority is to ensure the optimal health and well-being of babies and mothers and this is accomplished through the Section''s core activities in the realms of advocacy, education, outreach and support of clinicians and researchers.
|
|
American Conference for the Treatment of HIV (ACTHIV)
|
Meeting/ Workshop
|
CDC
|
OD/DPCPSI/OAR
|
The American Conference for the Treatment of HIV (ACTHIV) is a state-of-the-science conference for frontline health care professionals, in scientific collaboration with multiple Federal and independent agencies. The conference is designed for all frontline clinicians providing HIV care for various population groups.
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NINDS, NCATS, NCI, NIDA
|
The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the US Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health.
|
|
Analysis of Bisphenol A (BPA) Analogs
|
Research Initiative
|
CDC
|
NIEHS
|
With the Division of Laboratory Sciences, National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention (CDC) in Atlanta, GA (contacts Antonia Calafat and Sherry Ye), this no cost collaboration aimed to measure BPA analogs in a mouse disposition study. In return, the Fenton lab provided samples with BPAF so that the NCEH lab could develop a method for measuring BPAF for use in the National Health and Nutrition Examination Survey (NHANES) biomonitoring effort. Collaborating labs agreed to co-author research papers.
|
|
Analysis of Mycotoxins in Dust Samples From a Water Damaged Building
|
Research Initiative
|
CDC
|
NIEHS
|
These studies are developing methods to quantitate the levels of fungal products in dust samples from water damaged buildings so that biomarkers of effect, such as fungal specific antibodies, can be correlated with biomarkers of exposure.
|
|
Analysis of Volatile Organic Compound (VOC) Mixtures
|
Research Initiative
|
CDC
|
NIEHS
|
With the Division of Laboratory Sciences, National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention (CDC) in Atlanta, GA (contact Ben Blount), this no cost collaboration aimed to measure VOC metabolites in rat biological samples. CDC provided analytical chemistry, dosing instructions, and lab materials to collect the biological samples without contamination. Collaborating labs agreed to co-author research papers.
|
|
Anti-poliovirus Immune Assays and Testing Revertants from Clinical Trials of V-073, an Antiviral Agent
|
Research Initiative
|
FDA
|
NIAID
|
This project supports preclinical animal studies to obtain parameters essential for developing antiviral agents against poliovirus and to evaluate potential new antiviral agents.
|